Total Payments
$44,194
2022 Payments
$2,500
Companies
6
Transactions
33
Medicare Patients
645
Medicare Billing
$86,288
Payment Breakdown by Category
Consulting$28,663 (64.9%)
Other$14,775 (33.4%)
Food & Beverage$497.12 (1.1%)
Education$183.99 (0.4%)
Travel$75.04 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $28,663 | 12 | 64.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,775 | 10 | 33.4% |
| Food and Beverage | $497.12 | 8 | 1.1% |
| Education | $183.99 | 2 | 0.4% |
| Travel and Lodging | $75.04 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $37,630 | 23 | $0 (2022) |
| Genentech, Inc. | $4,210 | 3 | $0 (2021) |
| Seagen Inc. | $2,203 | 4 | $0 (2021) |
| Incyte Corporation | $70.98 | 1 | $0 (2021) |
| Kite Pharma, Inc. | $62.33 | 1 | $0 (2021) |
| ViiV Healthcare Company | $17.66 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,500 | 3 | AstraZeneca Pharmaceuticals LP ($2,500) |
| 2021 | $27,654 | 21 | AstraZeneca Pharmaceuticals LP ($22,018) |
| 2020 | $14,022 | 8 | AstraZeneca Pharmaceuticals LP ($13,112) |
| 2019 | $17.66 | 1 | ViiV Healthcare Company ($17.66) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 02/07/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
| 01/31/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/28/2021 | Seagen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 12/20/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: Oncology | ||||||
| 12/16/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $90.36 | General |
| Category: Oncology | ||||||
| 12/09/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/02/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,675.00 | General |
| Category: Oncology | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: Oncology | ||||||
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $108.46 | General |
| Category: Oncology | ||||||
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Travel and Lodging | In-kind items and services | $75.04 | General |
| Category: Oncology | ||||||
| 10/06/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $5,550.00 | General |
| Category: Oncology | ||||||
| 09/07/2021 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 09/06/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 08/26/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 08/20/2021 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 08/05/2021 | Seagen Inc. | ADCETRIS (Biological) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: Oncology | ||||||
| 07/14/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.51 | General |
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
| 06/16/2021 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $70.98 | General |
| Category: Oncology | ||||||
| 05/19/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $93.59 | General |
| Category: Oncology | ||||||
| 05/17/2021 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $62.33 | General |
| Category: CELLT | ||||||
| 03/17/2021 | Seagen Inc. | — | Education | In-kind items and services | $84.99 | General |
| 02/24/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $3,885.00 | General |
| Category: Oncology | ||||||
| 11/20/2020 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $910.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 16 | $2,880 | $1,030 |
| 2022 | 3 | 50 | 51 | $18,665 | $3,671 |
| 2021 | 7 | 258 | 516 | $156,538 | $42,519 |
| 2020 | 10 | 324 | 590 | $161,296 | $39,069 |
Total Patients
645
Total Services
1,173
Medicare Billing
$86,288
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $2,880 | $1,030 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $7,446 | $1,270 | 17.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 15 | $5,880 | $1,217 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 19 | $5,339 | $1,184 | 22.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 172 | $53,026 | $13,710 | 25.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 44 | 119 | $44,098 | $13,184 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 110 | $29,430 | $8,321 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 62 | 65 | $11,475 | $2,893 | 25.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $7,875 | $1,808 | 23.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $6,978 | $1,704 | 24.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 16 | $3,656 | $899.52 | 24.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 137 | $44,789 | $11,287 | 25.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 48 | 104 | $32,522 | $8,552 | 26.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 72 | 104 | $22,893 | $5,885 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 77 | $18,373 | $4,427 | 24.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 75 | 88 | $12,915 | $3,022 | 23.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 16 | $7,824 | $1,758 | 22.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 19 | 19 | $6,795 | $1,695 | 25.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 16 | 18 | $3,816 | $1,040 | 27.3% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 11 | 16 | $8,920 | $982.64 | 11.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 11 | 11 | $2,449 | $420.29 | 17.2% |
About Parth Rao
Parth Rao is a Hematology healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922365568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Parth Rao has received a total of $44,194 in payments from pharmaceutical and medical device companies, with $2,500 received in 2022. These payments were reported across 33 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($28,663).
As a Medicare-enrolled provider, Rao has provided services to 645 Medicare beneficiaries, totaling 1,173 services with total Medicare billing of $86,288. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Danville, PA
- Active Since 04/20/2012
- Last Updated 03/07/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1922365568
Products in Payments
- CALQUENCE (Drug) $37,576
- ADCETRIS (Biological) $2,019
- MONJUVI (Drug) $70.98
- Yescarta (Drug) $62.33
- DOVATO (Drug) $17.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.